Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers

Recruiting

Phase 2

Extracorporeal ShockwavesSafety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers

Sponsor:

Tissue Regeneration Technologies

Code:

NCT00366132

Conditions

Chronic Diabetic Foot Ulcers

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Extracorporeal Shockwaves

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Tissue Regeneration Technologies on 2006-08-18.